The use of combined OCPs is associated with an increased incidence of:
**Core Concept**
The use of combined oral contraceptive pills (OCPs) affects various physiological processes, including coagulation, lipid metabolism, and carbohydrate metabolism. This question requires an understanding of the pharmacological effects of combined OCPs on the body.
**Why the Correct Answer is Right**
Combined OCPs contain estrogen and progestin, which can increase the levels of clotting factors in the blood, thereby enhancing the risk of venous thromboembolism (VTE). This is due to the activation of coagulation pathways, particularly the extrinsic pathway, and the increased synthesis of clotting factors, such as factor VII, VIII, IX, and X. Additionally, estrogen can also lead to changes in lipid profiles, including increased levels of low-density lipoprotein (LDL) cholesterol and decreased levels of high-density lipoprotein (HDL) cholesterol, further contributing to the risk of VTE.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because while OCPs can affect carbohydrate metabolism, they are not primarily associated with an increased incidence of type 2 diabetes mellitus.
**Option B:** This option is incorrect because OCPs are not directly linked to an increased incidence of osteoporosis, although they can affect bone density in the long term.
**Option C:** This option is incorrect because OCPs are not primarily associated with an increased incidence of hypertension, although they can affect blood pressure in some individuals.
**Clinical Pearl / High-Yield Fact**
It is essential to note that the risk of VTE associated with OCPs is higher in women with a history of VTE, those with a family history of VTE, and those with other risk factors, such as obesity and smoking.
**Correct Answer:** D.